糖心传媒

Erin Calipari and colleagues have shown that peripheral administration of a neuroprotective cytokine may improve dopamine signaling problems associated with certain psychiatric disorders. Read More

Reyna Gordon has received a NIH Director鈥檚 New Innovator Award of $2.3 million for her project, 鈥淏iomarkers of Rhythmic Communication: Integrating Foundational and Translational Approaches.鈥�

聽Digna Velez Edwards and colleagues have now conducted the first genome-wide association study to search for genetic loci associated with differences in fibroid size and number. Read More

Using lesion network mapping, a recently developed technique for analyzing how the brain works, Ryan Darby studied free will perception related to movement decisions.

An international team led by researchers at Vanderbilt University Medical Center sheds new light on the cause of pulmonary fibrosis and demonstrates a way to impede the disease.

A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research program.

A trans-institutional team of researchers at Vanderbilt University Medical Center and Vanderbilt University has received an $11 million Cancer Moonshot grant to build a single-cell resolution atlas to map out the routes that benign colonic polyps take to progress to colorectal cancer, the third most common cancer among both men and women in the United States.

A new study by Harvey Murff finds that diabetics who take metformin have lower rates of liver cancer than those who take other diabetes drugs.

Stephen Deppen and colleagues have developed an updated map showing new areas of increased risk for a common lung infection.

Research led by Matthew Tyska gives new insight into the formation of the lining of the gut that helps us absorb nutrients and guard against illness.

Researchers led by melanoma researcher Douglas Johnson have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies.

An immune cell called CD8+ is supposed to attack disease, but it can also contribute to inflammation, which can lead to insulin resistance and type 2 diabetes.

Kasey Vickers has developed a new analytical method for to study small RNAs, a poorly understood component of the genome.

New research by an international team that includes Vanderbilt researchers shows how a common diabetes drug blocks glucose production by the liver, suggesting new avenues for treatment.

A Vanderbilt University Medical Center pilot study of treating late-life depression in nonsmokers with transdermal nicotine (nicotine patch) has yielded some promising results, but the study鈥檚 author cautions that more study is needed.

There鈥檚 promise in specific immune system peptides鈥攁mino acid compounds that signal cells how to function. In this case, they may be affecting brain activity and, by extension, drug cravings. Read More

The discovery of these antibodies could significantly improve the diagnosis and treatment of the leading cause of stomach illness in the world.

The discovery that high levels of bile acids appear to blunt cravings for cocaine could lead to new treatments for addiction.

A symptom related to hypertension may play a role in cognitive decline, according to new research by Angela Jefferson.

Vanderbilt researchers have discovered new insights into the treatment of chronic graft-versus-host-disease, a complication of bone marrow and stem cell transplants.